An open-label, investigator-blinded, stratified, randomized, parallel group study to compare the gastroprotective effects of PA 325 versus 81 mg enteric coated aspirin.

Trial Profile

An open-label, investigator-blinded, stratified, randomized, parallel group study to compare the gastroprotective effects of PA 325 versus 81 mg enteric coated aspirin.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Aspirin; Aspirin/omeprazole
  • Indications NSAID-induced gastrointestinal damage; Pain
  • Focus Adverse reactions
  • Sponsors POZEN
  • Most Recent Events

    • 11 Jul 2009 Results have been reported at the 22nd Congress of the International Society on Thrombosis and Haemostasis.
    • 09 Jan 2009 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top